Moreover, USP39 upregulation is identified in the pathogenesis of multiple cancers, including hepatocellular carcinoma, medullary thyroid carcinoma and renal cell carcinoma [27, 37, 38]. This evidence concerns the gene USP39 and hepatocellular carcinoma.